Coronavirus: UK Commits to Vaccine Trials, More PPE

British Health Minister Matt Hancock announced on Tuesday that clinical trials of a new coronavirus vaccine, developed by Oxford University in the UK, will start on Thursday. The government says it is “committing” to promoting vaccine development. At a regular meeting at the Prime Minister’s Office, Mr. Hancock explained that “the best way to destroy a new virus” is a vaccine.

VECTOR in Russia Developed Coronavirus Test To Test Almost 100 People At The Same Time

The numbers continue to increase in US and it is predicted that in many US states the peak of the coronavirus will not hit fully until May. Hence, it could mean the shut down of all non essential businesses can continue into May. In Canada, it seems the closures will last until at least June 30th. However, the situation is being accessed daily.

We Fight Coronavirus Through Cosmic Music

Music is the language of mankind. Bijan Norouz is an Iranian Composer, Musician, Entrepreneur and founder of Bijan Norouz Worldwide Music Co. that main activities include promoting scientific and conceptual music to expand astronomy and music engineering, Researching and Developing (R&D) music in space technologies, and creating music networking in future is for Space Cities, Space Habitat and for more people to know about cosmic music.

Coronavirus: China Announces First Clinical Vaccine Trial

China started the first clinical trial to test a vaccine against the new coronavirus, at a time when several countries are in a race to find effective treatment against the virus, the official press reported today. One hundred and eight volunteers, divided into three groups, received their first injections on Friday, according to the official English language newspaper Global Times.

Coronavirus: Vaccine Trial Starts, Louis Vuitton Mobilizes

The United States is scheduled to test a possible coronavirus vaccine with 45 volunteers. The trial of the coronavirus vaccine on 45 healthy, young volunteers will be carried out in Seattle, Washington on Monday, as reported by news sources. This trial is funded by the US government, and volunteers will receive various doses of the vaccine without being infected. The vaccine itself does not contain part of the actual coronavirus.

Coronavirus Fears Present Phenomenal Opportunities for Savvy Income Investors

As fears of the continued global spread of the Coronavirus (COVID-19) continue to drive financial markets to new lows, savvy investors should take note of the excellent opportunities that this massive global sell-off is creating.

The World Health Organization on Coronaviruses:

“Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).

Coronaviruses are zoonotic, meaning they are transmitted between animals and people.  Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans.”

Large-Scale HIV Vaccine Trial Launch Date Confirmed

A team of researchers said Monday that “no later than 2023” they will circulate the first vaccine against Human Immunodeficiency Virus (HIV), which will stop “at least 65%” the spread of the pandemic. They confirmed it in the framework of the 10th World Scientific Conference on HIV in Mexico. A human study will be carried out, involving 3,800 people and is estimated to begin in the coming months in the United States.